Characteristica | Total follow-up patients (n = 74) | Remission patients (n = 59) | Relapse patients (n = 15) | P value |
---|---|---|---|---|
Male gender, n (%) | 54 (73.0%) | 40 (67.8%) | 14 (93.3%) | 0.05 |
Age at onset (years) | 60.2 (23–79) | 63 (56–68) | 64 (52–66) | 0.3 |
White blood cell (109/L) | 5.8 (1.0–12.2) | 5.3 (4.2–7.3) | 5.5 (4.7–7.3) | 0.7 |
Eosinophils (%) | 5.5 (0.07–19.6) | 4.6 (2.25–7.65) | 4.3 (2.7–6.5) | 0.4 |
IgG (g/L) | 2189.7 (1010.0–5590.0) | 1795.0 (1570.0–2357.0) | 1970 (1730–2605) | 0.3 |
IgA (g/L) | 190.0 (56.1–432.0) | 187.0 (116.5–254.0) | 206.5 (109.0–257.8) | 0.8 |
IgM (g/L) | 77.1 (20.1–227.0) | 69.9 (43.6–101.5) | 68.0 (40.1–87.0) | 0.8 |
IgG4 (g/L) | 15.6 (0.54–73.2) | 10.9 (4.1–17.7) | 13.2 (5.7–20.6) | 0.3 |
IgG4-RD RI | 10.0 (2–36) | 8 (6–12) | 8 (6–14) | 0.2 |
Pancreato-hepato-biliary (n) | 30 | 23 | 7 | –b |
RPF/Aorta (n) | 2 | 2 | 0 | –b |
Head and neck-limited (n) | 8 | 8 | 0 | –b |
Mikulicz and systemic (n) | 34 | 26 | 8 | –b |